Grown Rogue International (GRIN) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
22 May, 2026Executive summary
Revenue grew 22% year-over-year to $32.4 million in 2025, driven by New Jersey market entry, offset by pricing pressure in Michigan and Oregon and the end of the Vireo consulting agreement.
Adjusted EBITDA rose 42% to $5.4 million (16.5% margin), with New Jersey contributing, but offset by higher overhead and market headwinds.
Focused on growth, scale, and expansion into Eastern markets, with significant progress in New Jersey, Minnesota, and Illinois.
Built out leadership and management teams, hiring key talent in construction, marketing, and state operations.
Emphasized resilience and adaptability amid challenging market conditions in Oregon and Michigan.
Financial highlights
Full-year 2025 revenue: $32.4 million (up from $26.6 million in 2024).
Adjusted EBITDA: $5.4 million (16.5% margin), up from $3.8 million (14.1% margin) in 2024.
GAAP net income: $3.2 million, compared to a net loss of $16.0 million in 2024.
Cash and cash equivalents at year-end: $11.4 million, up from $4.9 million.
Segment revenue: Oregon $11.1M (-8%), Michigan $10.0M (-22%), New Jersey $11.3M (first full year).
Outlook and guidance
2026 revenue guidance: $32–$35 million; Adjusted EBITDA: $6–$8 million.
2027 revenue guidance: $50–$58 million; Adjusted EBITDA: $14–$18 million.
Long-term objectives include 25% compound revenue growth and 35% compound profit growth.
Q1 2026 revenue expected to grow >20% year-over-year, led by New Jersey.
Minnesota facility construction targeted for Q3 2025 completion, with revenue contribution expected in Q1 2026.
Latest events from Grown Rogue International
- Q1 2026 revenue up 28% YoY to $9.2M; 2026 guidance raised to $34–$37M.GRIN
Q1 202619 May 2026 - Low-cost, quality-driven expansion and disciplined execution fuel strong growth and returns.GRIN
Company presentation12 May 2026 - Q2 2025 saw 4% pro forma revenue growth, margin pressure, and ongoing expansion efforts.GRIN
Q2 202522 Apr 2026 - Pro Forma Revenue up 26% year-over-year, driven by yield gains and new market expansion.GRIN
Q3 202517 Nov 2025 - Record revenue and aEBITDA growth, with expansion into New Jersey and Illinois underway.GRIN
Q2 202420 Aug 2025 - Q3 2024 revenue up 7% to $7.0M; New Jersey operations launched; Michigan margins improved.GRIN
Q3 202420 Aug 2025 - 2024 revenue rose 16% to $27.0M, with adjusted EBITDA up 27% and rapid New Jersey expansion.GRIN
Q4 202420 Aug 2025 - Expanding multi-state cannabis producer delivers strong growth, efficiency, and brand loyalty.GRIN
Investor Presentation20 Aug 2025 - Revenue up 7% year-over-year, but Adjusted EBITDA down 31% due to pricing pressure.GRIN
Q1 202520 Aug 2025